Skip to main content

Staphylococcal Infection

6
Pipeline Programs
4
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
1
0
2
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Destiny Pharma
Destiny PharmaUK - Brighton
1 program
1
MupirocinPhase 41 trial
Active Trials
NCT02284555Completed12Est. Nov 2014
Sharp Therapeutics
Sharp TherapeuticsPA - Pittsburgh
2 programs
1
1
Daptomycin 4 mg/kgPhase 3
V710Phase 1
MSD
MSDIreland - Ballydine
2 programs
1
1
Daptomycin 4 mg/kgPhase 3
V710Phase 1
Allergy Therapeutics
Allergy TherapeuticsUK - West Sussex
2 programs
1
Mupirocin calciumPhase 21 trial
CephalexinPHASE_2_31 trial
Active Trials
NCT00729937Completed2,265Est. Jun 2013
NCT01827358Completed155Est. Jun 2016

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Destiny PharmaMupirocin
Allergy TherapeuticsCephalexin
Allergy TherapeuticsMupirocin calcium

Clinical Trials (3)

Total enrollment: 2,432 patients across 3 trials

NCT02284555Destiny PharmaMupirocin

Study to Assess Eradication of Nasal Carriage of Staphylococcus Aureus (SA) With Mupirocin (Bactroban 2% Nasal Ointment)

Start: Aug 2014Est. completion: Nov 201412 patients
Phase 4Completed
NCT00729937Allergy TherapeuticsCephalexin

Strategies Using Off-Patent Antibiotics for Methicillin Resistant S. Aureus "STOP MRSA"

Start: Apr 2009Est. completion: Jun 20132,265 patients
Phase 2/3Completed
NCT01827358Allergy TherapeuticsMupirocin calcium

Safety and Efficacy of Mupirocin in Eradicating Colonization With S. Aureus in Critically Ill Infants

Start: Apr 2014Est. completion: Jun 2016155 patients
Phase 2Completed

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 late-stage (Phase 3) programs, potential near-term approvals
4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.